Andrew Callos, EVP, Chief Commercial Officer at CYTOKINETICS INC (CYTK), sold 8,542 shares at $62.15 ($531K) on 2026-03-17, disclosed to the SEC on 2026-03-18.
Seasonal sale ($531k) by EVP, Chief Commercial Officer — this insider has traded CYTK in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $62.15 | 2,916 | $181K | 34.1% |
| 2 | $62.15 | 5,626 | $350K | 65.9% |
| Total | $62.15 avg | 8,542 | $531K | 100% |
| Filing → |
| CYTK | SELL | 2026-07-02 | $1.3M | — | Filing → |
| CYTK | SELL | 2026-06-01 | $1.1M | — | Filing → |
| CYTK | SELL | 2026-05-05 | $875K | — | Filing → |